Target intelligence / Profile preview

ARGLU1 divergent transcript (ARGLU1-DT)

Target
ARGLU1-DT
Molecular classification
Long non-coding RNA (lncRNA)
01

Overview

ARGLU1 divergent transcript (ARGLU1-DT) is a long intergenic non-protein coding RNA (lncRNA) arising from the region near the ARGLU1 gene. It is known by several aliases, including LINC00443 and LINC00551. ARGLU1-DT belongs to the lncRNA class and is implicated in the regulation of gene expression, particularly through modulating pre-mRNA splicing events in partnership with the ARGLU1 protein. Functional studies suggest that the transcript is involved in controlling the localization and phase separation of the ARGLU1 protein at nuclear speckles, which may influence gene regulatory mechanisms, especially alternative splicing[1]. There are limited disease associations, with some data suggesting a role in certain cancers such as esophageal cancer[3], though its direct involvement and mechanisms remain unclear. No approved drugs, biomarker applications, or safety concerns have been documented for ARGLU1-DT. It should be recognized as a regulatory non-coding RNA rather than a protein-coding therapeutic target, receptor, enzyme, or transporter.

Other names
LINC00443LINC00551long intergenic non-protein coding RNA 443long intergenic non-protein coding RNA 551
02

Biological functions

Regulation of RNA splicing (through interaction with ARGLU1 protein)Modulation of gene expressionPhase separation of RNA-binding proteins (regulating nuclear subcompartment localization)
03

Disease associations

Reported association with esophageal cancer

Beyond the preview

Go deeper on ARGLU1 divergent transcript (ARGLU1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARGLU1 divergent transcript (ARGLU1-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call